BackCASI Pharmaceuticals Overview

CASI Pharmaceuticals Operating Income

Operating Income for CASI.

Quarterly Operating Income

$-10677000.00
↑ 26.15% YoY

As of Sep 30, 2025

Annual Operating Income (TTM)

$-45095000.00
↑ 20.47% YoY

Trailing 12 months ending Sep 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin